Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05075512
Status:
RECRUITING
Last Update Posted:
2021-10-12
First Post:
2021-08-09
Brief Title:
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
Sponsor:
Organization:
Zhejiang Cancer Hospital